Folotyn (Allos Therapeutics)
Welcome to the PulseAid listing for the Folotyn drug offered from Allos Therapeutics. This Folate Analog Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allos Therapeutics |
| NON-PROPRIETARY NAME: | pralatrexate |
| SUBSTANCE NAME: | PRALATREXATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Folate Analog Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-09-24 |
| END MARKETING DATE: | 0000-00-00 |
Folotyn HUMAN PRESCRIPTION DRUG Details:
| Item Description | Folotyn from Allos Therapeutics |
| LABELER NAME: | Allos Therapeutics |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2009-09-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 48818-001_f4201d12-9f89-4ce0-a2c9-66d2bcaf12ca |
| PRODUCT NDC: | 48818-001 |
| APPLICATION NUMBER: | NDA022468 |
Other PRALATREXATE Pharmaceutical Manufacturers / Labelers:
